Canopy Growth publishes FY2026 annual report
CGC•Annual report highlights tighter operating focus and commercial progress
Canopy Growth filed its fiscal 2026 annual report, highlighting progress from a tighter operating focus and a stronger commercial platform.
- Canadian medical cannabis strengthened, adult-use returned to growth, and international medical expanded as regulatory frameworks evolved in Europe and Australia.
- The company completed the acquisition of MTL Cannabis on March 16, 2026, positioning it as Canada’s top medical cannabis provider by revenue.
- Storz & Bickel shifted to a refreshed plan centered on U.S. sales and marketing, product innovation, and supply chain optimization.
- Balance sheet actions included a US$150 million senior secured term loan, which repaid the prior first lien term loan facility.
